BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21666481)

  • 1. Pharmacological manipulation of dendritic cells in the pursuit of transplantation tolerance.
    Leishman AJ; Silk KM; Fairchild PJ
    Curr Opin Organ Transplant; 2011 Aug; 16(4):372-8. PubMed ID: 21666481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taming the lions: manipulating dendritic cells for use as negative cellular vaccines in organ transplantation.
    Turnquist HR; Thomson AW
    Curr Opin Organ Transplant; 2008 Aug; 13(4):350-7. PubMed ID: 18685329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing dendritic cells for the induction of transplantation tolerance.
    Silk KM; Fairchild PJ
    Curr Opin Organ Transplant; 2009 Aug; 14(4):344-50. PubMed ID: 19417656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Handbook of experimental pharmacology "dendritic cells": the use of dexamethasone in the induction of tolerogenic DCs.
    van Kooten C; Stax AS; Woltman AM; Gelderman KA
    Handb Exp Pharmacol; 2009; (188):233-49. PubMed ID: 19031029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing regulatory T cells for transplant tolerance in the clinic through mTOR inhibition: myth or reality?
    Zuber J; Hermine O; Chatenoud L; Legendre C
    Curr Opin Organ Transplant; 2011 Dec; 16(6):606-13. PubMed ID: 21971509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yin and yang of cytokine regulation in solid organ graft rejection and tolerance.
    Wadia PP; Tambur AR
    Clin Lab Med; 2008 Sep; 28(3):469-79, vii-viii. PubMed ID: 19028264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of tolerogenic dendritic cells by vitamin D receptor agonists.
    Adorini L; Penna G
    Handb Exp Pharmacol; 2009; (188):251-73. PubMed ID: 19031030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and the balance of Treg and Th17 cells in transplant rejection and tolerance.
    Hanidziar D; Koulmanda M
    Curr Opin Organ Transplant; 2010 Aug; 15(4):411-5. PubMed ID: 20613526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressive dendritic cells as a tool for controlling allograft rejection in organ transplantation: promises and difficulties.
    Ehser S; Chuang JJ; Kleist C; Sandra-Petrescu F; Iancu M; Wang D; Opelz G; Terness P
    Hum Immunol; 2008 Mar; 69(3):165-73. PubMed ID: 18396208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells,tolerance and therapy of organ allograft rejection.
    Raimondi G; Thomson AW
    Contrib Nephrol; 2005; 146():105-120. PubMed ID: 15567925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of IL-4 and Th2 responses in allograft rejection and tolerance.
    Tay SS; Plain KM; Bishop GA
    Curr Opin Organ Transplant; 2009 Feb; 14(1):16-22. PubMed ID: 19337141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of kidney allograft tolerance by soluble CD83 associated with prevalence of tolerogenic dendritic cells and indoleamine 2,3-dioxygenase.
    Lan Z; Ge W; Arp J; Jiang J; Liu W; Gordon D; Healey D; DeBenedette M; Nicolette C; Garcia B; Wang H
    Transplantation; 2010 Dec; 90(12):1286-93. PubMed ID: 21076370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance induction.
    Kupiec-Weglinski JW
    Curr Opin Organ Transplant; 2008 Aug; 13(4):331-2. PubMed ID: 18685325
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immune tolerance induced by IL-10 and methylprednisolone modified dendritic cells in vitro].
    Li X; Dou KF; Liu HL; Zhang FQ; Cai L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 May; 23(5):436-8. PubMed ID: 17488605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifiers of complement activation for prevention of antibody-mediated injury to allografts.
    Hughes PD; Cohney SJ
    Curr Opin Organ Transplant; 2011 Aug; 16(4):425-33. PubMed ID: 21681097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in immunosuppressive therapy for prevention of renal allograft rejection.
    Lunsford KE; Barbas AS; Brennan TV
    Curr Opin Organ Transplant; 2011 Aug; 16(4):390-7. PubMed ID: 21666473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique aspects of rejection and tolerance in liver transplantation.
    Knechtle SJ; Kwun J
    Semin Liver Dis; 2009 Feb; 29(1):91-101. PubMed ID: 19235662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of rapamycin in the induction of tolerogenic dendritic cells.
    Fischer R; Turnquist HR; Taner T; Thomson AW
    Handb Exp Pharmacol; 2009; (188):215-32. PubMed ID: 19031028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaching the promise of operational tolerance in clinical transplantation.
    Bishop GA; Ierino FL; Sharland AF; Hall BM; Alexander SI; Sandrin MS; Coates PT; McCaughan GW
    Transplantation; 2011 May; 91(10):1065-74. PubMed ID: 21544029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell immunotherapeutics: emerging roles in solid organ transplantation.
    Jordan SC; Kahwaji J; Toyoda M; Vo A
    Curr Opin Organ Transplant; 2011 Aug; 16(4):416-24. PubMed ID: 21666479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.